BIO-KEY INTERNATIONAL, INC.

(BKYI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

BIO key International : Maxim Upgrades BIO-key International to Buy From Hold; Price Target is $6

03/26/2021 | 09:37am EDT


© MT Newswires 2021
All news about BIO-KEY INTERNATIONAL, INC.
05/16TRANSCRIPT : BIO-key International, Inc., Q1 2022 Earnings Call, May 16, 2022
CI
05/16Earnings Flash (BKYI) BIO-KEY INTERNATIONAL Posts Q1 Loss $-0.12, vs. Street Est of $-0..
MT
05/16Earnings Flash (BKYI) BIO-KEY INTERNATIONAL Posts Q1 Revenue $1.9M, vs. Street Est of $..
MT
05/16Identity and Access Management Cyber-Security Provider BIO-key's Q1 Revenue Improved to..
AQ
05/16BIO-key International, Inc. Provides Revenue Guidance for the Full Year 2022
CI
05/16BIO-key International, Inc. Reports Earnings Results for the First Quarter Ended March ..
CI
05/10BIO-key, Provider of Identity & Access Management Cybersecurity Solutions, Hosts Q1 Inv..
AQ
05/10BIO-KEY VP OF PRODUCT, KIMBERLY BIDD : Power 100 List for the Second Year in a Row
AQ
05/09YYK Enterprises Selects PortalGuard IAM Platform to Secure Data Access and Provide Pass..
AQ
05/09BIO-Key International, Inc. Announces YYK Enterprises Operations, LLC Selects Bio-Key's..
CI
More news
Analyst Recommendations on BIO-KEY INTERNATIONAL, INC.
More recommendations
Financials (USD)
Sales 2022 12,0 M - -
Net income 2022 -1,60 M - -
Net cash 2022 4,60 M - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 16,4 M 16,4 M -
EV / Sales 2022 0,98x
EV / Sales 2023 0,72x
Nbr of Employees 51
Free-Float 90,7%
Chart BIO-KEY INTERNATIONAL, INC.
Duration : Period :
BIO-key International, Inc. Technical Analysis Chart | BKYI | US09060C4087 | MarketScreener
Technical analysis trends BIO-KEY INTERNATIONAL, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 1,95 $
Average target price 5,00 $
Spread / Average Target 156%
Managers and Directors
Michael W. DePasquale Co-Chief Executive Officer & Director
Cecilia C. Welch Controller
Mira K. LaCous Chief Technology Officer
James Sullivan SVP-Global Sales, Strategy & Business Development
Thomas E. Bush Independent Director
Sector and Competitors